Drug Database
Back to search

Switzerland· 17353012

Buscopan, Dragées

A butylscopolamine product containing scopolamini butylbromidum, registered in Switzerland by Opella Healthcare Switzerland AG and dispensed under Swissmedic category D. The same ATC class is registered in 11 of our 19 countries.

Cat D (Swissmedic)ATC A03BB01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedBuscopan, DragéesATCA03BB01REGISTER NO.17353012PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about scopolamini butylbromidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Butylscopolamine is registered in 11 of 19 countries.

Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search butylscopolamine products by name

Butylscopolamine · ATC A03BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
scopolamini butylbromidum
Manufacturer
Opella Healthcare Switzerland AG
Country
Switzerland (CH)
ATC code
A03BB01
ATC class
Butylscopolamine
Defined daily dose
60 mg, O
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A03BB01

Butylscopolamine, as other registers publish it.

All butylscopolamine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9b8e537-763b-425c-b2ad-d95fb15882ff
GET /v1/drugs/a9b8e537-763b-425c-b2ad-d95fb15882ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about butylscopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console